Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative)

v3.7.0.1
Subsequent Events (Details Narrative)
Feb. 27, 2017
USD ($)
Subsequent Event [Member] | License Agreement [Member] | Sellas Life Science Group [Member]  
Future Payments $ 358,000,000